Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807534-77-5
1146195-72-3
1818294-35-7
1807539-04-3
1454662-54-4
2086689-04-3
1802907-92-1 | Methyltetrazine-peg5-nhs ester | AA019E0N | MFCD28334559
2055023-77-1 | Azido-PEG3-S-PEG3-azide | AA019E49 | MFCD30182054
2112731-51-6 | N-(Azido-PEG3)-N-Boc-PEG3-NHS ester | AA019E9D | MFCD30723237
2182602-16-8 | N-(NHS-PEG3)-N-bis(PEG3-azide) | AA019EDS | MFCD31561132
360059-80-9 | Ethyl 2-aminohex-5-enoate | AA019EHH | MFCD18910143
143491-58-1 | ((2S,5R)-5-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl butyrate | AA019EL0 | MFCD30185763
162222-14-2 | N-(2-(3,5-dichlorophenyl)propan-2-yl)acetamide | AA019ENL | MFCD30828715
70216-78-3 | 2-[(3-fluorophenyl)methyl]isoindole-1,3-dione | AA019EQV | MFCD05266032
1702300-72-8 | tert-Butyl 4-(3-chloropropyl)-4-cyanopiperidine-1-carboxylate | AA019EU8 | MFCD22384468
837423-56-0 | 2-chloro-N-(2,4-diMethoxyphenyl)pyriMidin-4-aMine | AA019EX9 | MFCD17293254
